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Abstract
Introduction. Persons with high or low body mass index (BMI), involved in clinical or mechanistic trials involving exercise
testing, might estimate dyspnoea differently from persons with a normal BMI.
Aims. Our objective was to investigate the relationship between BMI and dyspnoea during exercise in normal subjects with
varying BMI.
Material and methods. A total of 37 subjects undertook progressive exercise testing. Subjects were divided into three groups:
underweight (UW), normal weight (NW), and overweight (OW). Dyspnoea was estimated using the visual analogue scale
(VAS). Spirometry, maximum voluntary ventilation (MVV), and respiratory muscle strength (RMS) were measured.
Results and discussion. The intercept of the VAS/ventilation relationship was significantly higher in NW subjects compared to
UW (P = 0.029) and OW subjects (P = 0.040). Relative to the OW group, FVC (P = 0.020), FEV1 (P = 0.024), MVV
(P = 0.019), and RMS (P = 0.003) were significantly decreased in the UW group. The greater levels of dyspnoea in UW subjects
could possibly be due to decreased RMS. Healthy persons should aim to achieve an optimum BMI range to have the lowest
exercise-induced dyspnoea.
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Introduction
Dyspnoea is a common symptom in many respiratory
disorders, and it is also seen in healthy subjects
during exercise (1). Increasing grades of dyspnoea
in patients have been associated with greater impair-
ment in quality of life (2). After adjusting for age,
smoking history, and occupation, dyspnoea has also
been shown to be predictive of mortality in elderly
people (3). Assessments of dyspnoea during exercise
have been made in healthy subjects (4), in chronic
obstructive pulmonary disease (COPD) patients to
study the benefits of inspiratory muscle training (5),
and in COPD patients investigating the effect of
therapeutic agents (6).
Abnormalities in body mass index (BMI) have been
shown to affect exercise-induced dyspnoea in obese
cardiac patients (7). In this study, obese patients were
more breathless compared to overweight (OW) or
normal weight (NW) patients, during a progressive
exercise test. With regard to underweight (UW) and
OW subjects and their estimations of exercise-
induced dyspnoea, no study could be found in the
literature. Previous studies have also shown that
abnormal BMI can be related to pulmonary compli-
cations. For example, there is a relationship between
low BMI and an increased risk of developing
COPD (8). Similarly, having a low or high BMI
has been associated with a greater prevalence of
asthma (9).
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Therefore, is it possible that UW or OW persons,
if involved in dyspnoea testing, for clinical trials or
for mechanistic studies of the effects of dyspnogenic
agents, might estimate dyspnoea differently relative to
NW persons? A recent breathlessness survey has
suggested that future clinical studies for breathless-
ness should consider stratification by BMI (10). The
purpose of the present study was to determine
whether a relationship exists between BMI and the
perception of dyspnoea during exercise in UW, NW,
and OW subjects.
Material and methods
This was a prospective study, in which healthy
subjects underwent exercise and lung function
testing. Subjects undertook progressive symptom-
limited sub-maximal bicycle ergometry during the
course of which dyspnoea was estimated each
minute using a visual analogue scale (VAS). Exercise
testing was conducted twice, to familiarize the sub-
jects with the procedure; the time period between
tests was 1 week.
Thirty-seven healthy subjects (all male) were
studied. All were volunteers and were recruited
from the staff and students of the Aga Khan Uni-
versity (AKU), Karachi, Pakistan, and all were
Pakistani. All were non-smokers, with no history
of cardiopulmonary or other chronic disease. Prior
to participation, the subjects completed a pre-
exercise testing screening questionnaire and a resting
electrocardiogram (ECG). Their lung function
was assessed by spirometry. Based on their BMI,
subjects were divided into three groups: underweight
(n = 13; < 18.5 kg/m2), normal weight (n = 12; 18.5–
24.9 kg/m2), and overweight (n = 12; > 25.0 kg/m2).
Mean BMI (± SD) was 22.6 ± 5.2 kg/m2, range 14.5–
35.5 kg/m2. Mean age (± SD) was 21.7 ± 4.5 years,
range 18–37 years. All subjects were sedentary
individuals with minimal levels of habitual activity.
Experiments were performed at approximately the
same time of the day, at least 2 hours after a light meal.
Informed consent was obtained from the subjects, and
the study was approved by the AKU Human Subject
Protection Committee on 15 June 2001 and per-
formed according to the Declaration of Helsinki.
Height and weight were taken on a combined stadi-
ometer/weighing scale (Seca, Hamburg, Germany),
with subjects wearing light indoor clothing and no
shoes.
The exercise tests were conducted on an electri-
cally braked bicycle ergometer (Tunturi, Piispanristi,
Finland). The subject breathed through a valve box,
which allowed inspiration from room air. Inspired
ventilation (VI) and respiratory frequency were
measured using a rotating vane anemometer and
ventilation monitor (PK Morgan Ltd, Chatham,
Kent, UK). The ECG (Datascope, Mahwah,
New Jersey, USA) was monitored throughout the
test. Heart rate and oxygen saturation were monitored
throughout the experiment using a pulse oximeter
(Ohmeda, Madison, Wisconsin, USA), attached via
a finger probe. The pulse oximeter and ventilation
monitor were connected to a personal computer
which processed and recorded data every 15 s.
Once attached to the equipment, the subject was
given a few min to become acquainted to the
apparatus. Expired gases were not measured.
The VAS was used to quantify dyspnoea intensity,
and it was drawn as a 100 mm linear line on a card,
the extremes of which were labelled ‘not at all breath-
less’ (0 mm) and ‘extremely breathless’ (100 mm).
The subject was given approximately 5 s to mark
his response in pencil on the card which was held
before him at the end of each minute of the exercise
procedure. A separate card was used every min.
Before the start of each experiment the term
‘breathlessness’ was defined to the subjects as a sense
of breathing discomfort, a feeling that breathing was
not sufficient for the needs they thought they had.
It was emphasized that they should not confuse
breathlessness with other sensations associated with
exercise, such as leg fatigue. During both exercise
tests, subjects were asked to use the same criteria to
estimate their dyspnoea.
Data were recorded for 1 min at rest, and then
the subject started unloaded pedalling, for 1 min,
at a frequency of between 50–60 revolutions per
min. Thereafter, the work rate was increased 20 watts
per min until a symptom-limited sub-maximum was
reached. The test was stopped if the subject indica-
ted chest pain, showed pallor, severe desaturation, a
heart rate within 10 beats min-1 of the maximum
predicted for that individual (4), indicated greater
than 90 mm on the VAS, or if there were any signifi-
cant ECG abnormalities.
Respiratory muscle strength (RMS) was calculated
by the addition of the maximum static inspiratory
(PImax) and expiratory (PEmax) mouth pressures
divided by two (11). PImax and PEmax were measured
at residual volume and total lung capacity, respec-
tively (Med Graphic Profiler, Pulmonary Diagnostic
System; Medical Graphics Corp, St Paul, Minnesota,
USA). Tests were conducted according to American
Thoracic Society (ATS)/European Respiratory
Society recommendations (12). Three measurements
were taken, and the highest values were chosen,
irrespective of the test. This test could not be
performed on three subjects, as they were either on
leave or had examinations. Although PImax values are
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negative, for clarity they were reported as positive
numbers, as has been done previously (13).
Spirometry and maximum voluntary ventilation
(MVV) were performed on a Compact Vitalograph
electronic spirometer (Vitalograph, Maids Moreton,
Buckingham, UK). The apparatus was calibrated daily
with a 1 litre calibration syringe. Tests were conducted
according to ATS recommendations (14). For
spirometry, three to five manoeuvres were performed
after adequate rest. The highest lung function values
were chosen, irrespective of the test. MVV was
measured for 15 s, and the frequency of duration
exceeded 80 breaths min-1 in all subjects. MVV was
performed twice, and the highest value was chosen.
When the subjects’ VAS estimation was plotted
against VI, a linear VAS/VI relationship was observed.
Correlating VAS against ventilation has been previ-
ously performed (4,15,16). Linear correlation was
applied, and from this the x-axis intercept (L min-1)
and the slope (mm min L-1) were calculated as done
before (4). The x-axis intercept will be referred to as
the intercept. As the first test was to familiarize sub-
jects, only exercise and breathlessness data from
week two were analysed. Heart rate was analysed as
the heart rate after the first min of exercise (fC1min),
heart rate at 60 watts of exercise (fC60), and maximum
heart rate (fCmax).
For dyspnoea comparisons between groups,
one-way ANOVA was used for analysis. Bonferroni’s
post hoc analysis was used for comparisons between
specific groups. Stepwise multiple linear regression
analysis of the slope and intercept against predictor
variables such as age, height, etc. was also made. All
spirometric test data were pooled and analysed using
repeated measures analysis of covariance
(ANCOVA), including age and height and two
dummy variables to describe the three groups. All
tests were two-tailed, and the level of probability taken
as significance was 5% (P < 0.05).
Results
Lung function
Relative to the OW group, forced vital capacity (FVC)
(P = 0.020), forced expiratory volume in 1 second
(FEV1) (P = 0.024), and MVV (P = 0.019) were
significantly decreased in the UW group, while FVC
was lower in NW subjects (P = 0.028) (Table I). The
PImax (P = 0.008), PEmax (P = 0.010), and RMS
(P = 0.003) were also significantly lower for the
UW group compared to the OW group. Age, height,
FEV1/FVC % ratio, and peak expiratory flow (PEF)
did not show any significant changes between groups.
Results for spirometry and MVV are presented as
actual values and not corrected for age and height.
One reason for this was that there were no significant
differences in age and height between groups, and
secondly there are no standardized values for the
Pakistani population. However, we did analyse the
Table I. Mean (± SD) anthropometric and lung function variables for all subjects in underweight, normal weight, and overweight
groups (n = 37).




(n = 12) P valuea
Age (years) 21.4 ± 4.2 22.0 ± 4.3 21.7 ± 5.3 0.953
BMI (kg m-2) 17.4 ± 1.1 22.3 ± 2.1 28.7 ± 2.9 <0.0001
Height (cm) 174 ± 6 173 ± 4 175 ± 9 0.809
Weight (kg) 52 ± 5 66 ± 8 89 ± 15 <0.0001
FVC (L) 4.13 ± 0.65 4.15 ± 0.61 5.10 ± 1.18 0.010
FEV1 (L) 3.32 ± 0.60 3.48 ± 0.61 4.12 ± 0.88 0.020
FEV1/FVC % ratio (%) 79.4 ± 7.8 83.7 ± 6.3 80.9 ± 3.1 0.226
PEF (L min-1) 511.8 ± 123.5 556.9 ± 103.5 588.0 ± 103.4 0.238
MVV (L min-1) 136.2 ± 29.8 143.7 ± 32.0 170.6 ± 41.6 0.048
PImax (cmH2O)
b 79.8 ± 34.0 106.3 ± 36.8 144.9 ± 66.4 0.010
PEmax (cmH2O)
b 80.4 ± 24.3 107.3 ± 19.6 111.9 ± 25.7 0.006
RMS (cmH2O)
b 80.1 ± 23.5 106.9 ± 25.6 128.5 ± 43.4 0.004
aDifference between three groups.
bn = 12, 12, and 10 per group, respectively.
BMI = body mass index; FEV1 = forced expiratory volume in 1 s; FEV1/FVC % ratio = ratio of FEV1 to FVC; FVC = forced vital capacity;
MVV = maximum voluntary ventilation; PEF = peak expiratory flow; PEmax = maximum static expiratory mouth pressure; PImax = maximum
static inspiratory mouth pressure; RMS = respiratory muscle strength.
Body mass index and exercise dyspnoea 385
data as a percentage of Caucasian references values,
which took into account age and height, and found
no disparity between the two methods of analysis
in terms of significantly different variables. Using
ANCOVA, no significant difference was found in
the repeated spirometric data between the three
BMI groups, taking into account both subject height
and age, FVC (P = 0.71), FEV1 (P = 0.76), FEV1/FVC
% ratio (P = 0.93), or PEF (P = 0.93).
Exercise-induced dyspnoea
The relationship between VAS and VI was significant
for all subjects (P < 0.05) and effectively linear for
all groups. The mean (± SD) r2 (coefficient of deter-
mination), for all experiments was 0.959 ± 0.030
(range 0.882–0.999); r2 was significantly different
between groups (Table II). There was a wide range
of values for the slope (0.6–12.1 mm min L-1) and
intercept (3.4–42.0 L min-1) of the VAS/VI
relationship in all subjects.
The VAS/VI intercept (Table II) in the NW group
was significantly higher than in both the UW
(P = 0.029) and OW groups (P = 0.040). UW max-
imum work-load (Wmax) per kg body mass values
were significantly higher than corresponding OW
values (P = 0.001). There were no statistically signif-
icant differences in VAS/VI slope, Wmax, maximum
ventilation (VImax), fC1min, fC60, and fCmax between
the groups tested (Table II). The mean intercept and
slope values of the relationships between VAS and
inspired ventilation for the three groups have been
graphically illustrated (Figure 1).
Regression analyses
Linear correlations of BMI, lung function, exercise,
and dyspnoea parameters were made, combining data
from all groups (Table III). BMI had significant
positive correlations with RMS, PImax, MVV, FVC,
FEV1, and PEF and a negative correlation with fC60.
The PImax showed positive relationships against FVC
and FEV1, while it showed a negative correlation with
Wmax/body mass. The slope of the VAS/VI relation-
ship was negatively correlated with RMS and r2. The
fC60 had significant negative correlations with MVV,
PImax, FVC, and FEV1.
Using the stepwise method, significant models
emerged for the multiple regression analysis of the
VAS/VI slope (F3,31 = 29.330, P < 0.00001, adjusted
r2 = 0.714) and VAS/VI intercept (F1,33 = 218.824,
Table II. Comparison of mean (± SD) indices of the breathlessness/ventilation relationship and exercise variables between underweight,






(n = 12) P valuea
r2 value 0.94 ± 0.03 0.97 ± 0.02 0.96 ± 0.03 <0.050
VAS/VI slope (mm min L
-1) 2.73 ± 2.99 2.05 ± 1.40 1.96 ± 1.04 0.575
VAS/VI intercept (L min
-1) 16.1 ± 5.84 22.7 ± 7.54 17.1 ± 3.96 0.022
Wmax (W) 113.9 ± 25.0 120.0 ± 29.5 126.7 ± 27.4 0.510
Wmax per kg (W/kg) 2.17 ± 0.53 1.80 ± 0.36 1.46 ± 0.39 0.001
VImax (L min
-1) 48.0 ± 12.0 45.3 ± 11.2 48.6 ± 8.9 0.725
fC1min (beats min
-1) 91.8 ± 12.9 88.0 ± 13.5 91.9 ± 13.6 0.711
fC60 (beats min
-1) 123.7 ± 15.4 116.8 ± 12.3 113.8 ± 16.3 0.239
fCmax (beats min
-1) 153.0 ± 22.0 145.7 ± 18.8 144.7 ± 19.1 0.533
aDifference between three groups.
fC1min = heart rate after 1 min of exercise; fC60 = heart rate at 60 watts of exercise; fCmax =maximum heart rate; r2 = coefficient of determination;
VAS/VI = relationship of visual analogue scale against inspired ventilation; VImax = maximum ventilation; Wmax = maximum work-load; Wmax




















UW = under weight
NW = normal weight




Figure 1. A representation of the mean changes in the VAS/VI
relationship for all subjects in the three BMI groups. There were no
differences in the slope values, but the NW intercept value was
significantly greater relative to values for UW and OW subjects.
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P < 0.00001, adjusted R square = 0.865). Significant
predictor variables for the slope are the FEV1/FVC %
ratio, VImax, and PEmax (Table IV). For the inter-
cept, the VAS/VI r
2 value was the only significant
variable. Residuals for the slope and intercept from
the regression were plotted against BMI, PImax,
and PEmax; data points were randomly distributed
around zero.
Discussion
The main finding of our study was that UW and OW
subjects, relative to NW subjects, showed greater
levels of dyspnoea during exercise, due to a lower
VAS/VI intercept, indicating that these subjects esti-
mated their sensations of exercise-induced dyspnoea
earlier than NW subjects. We also found that FVC,
FEV1, and MVV were significantly decreased in the
UW group, relative to the OW group; changes in FVC
and FEV1 are in agreement with a previous report
(17). An earlier study showed a positive correlation
between BMI with both FVC and FEV1 (18).
Schachter et al. suggested that an inferior lung
function of UW subjects could be due to a decrease
in RMS (17). FVC, though not FEV1, in our OW
subjects was significantly greater relative to NW sub-
jects. In contrast, previous data reported no signifi-
cant differences in FVC and FEV1 between OW and
NW subjects (17).
The present study also showed that both RMS and
PImax were significantly lower for the UW group
compared to the OW group; both values showed a
positive correlation with body mass, in agreement
with previous work in healthy subjects (19). Com-
bined PEmax data for UW patients without lung
disease and controls have also shown a significant
positive correlation with body weight (11).
Diaphragm muscle mass has been significantly
correlated to body mass in normal subjects after
autopsy (20). This could be a basis for the significant
relationship between BMI with RMS and PImax in the
present study. The higher RMS of the OW subjects
may be due to the increase in body mass improving
their muscle strength (21) and vice versa in UW
subjects.
PImax and several spirometric variables were signif-
icantly negatively correlated to fC60, indicative that
persons with lower exercise heart rates had better lung
function. This is supported by work showing an
association between physical activity and lung func-
tion (22).
At any given level of ventilation, UW and OW
subjects were significantly more breathless than
NW subjects. NW subjects were the least breathless.
The relationship between dyspnoea and ventilation
was linear, as shown by the r2 value, and had a large
inter-subject variation, consistent with previous
work (1,4).
It is interesting to note that although our VAS/VI
slope was not significantly affected by changes in
BMI, it had a significant negative correlation with
RMS and PEmax, indicating that a decrease in muscle
strength was associated with greater exercise
dyspnoea.
Obesity increases dyspnoea (17,23), and reasons
for this include an increase in the work of brea-
thing, due to an increased elastic resistance to disten-
sion (24), increased respiratory or nasopharyngeal
resistance (25), increased pulmonary venous pressures
Table III. Linear correlation coefficients for selected correlations,
using data from all subjects.
Correlations
r value
(correlation coefficient) P value
BMI versus RMS +0.448 0.008
BMI versus MVV +0.419 0.009
BMI versus FVC +0.454 0.004
BMI versus PEF +0.333 0.044
BMI versus fC60 –0.339 0.040
PImax versus FVC +0.409 0.018
PImax versus Wmax per kg –0.373 0.030
VAS/VI slope versus RMS –0.377 0.028
VAS/VI slope versus r
2
–0.407 0.012
fC60 versus MVV –0.453 0.005
fC60 versus PImax –0.378 0.027
fC60 versus FVC –0.490 0.002
BMI = body mass index; fC60 = heart rate at 60 watts of exercise;
FVC = forced vital capacity; MVV = maximum voluntary ventila-
tion; PEF = peak expiratory flow; PImax = maximum static inspi-
ratory mouth pressure; r2 = coefficient of determination;
RMS = respiratory muscle strength; VAS/VI = relationship of visual
analogue scale against inspired ventilation;Wmax per kg =maximum
work-load per kg body mass.
Table IV. Multiple regression analysis of the VAS/VI slope and






beta coefficient P value
VAS/VI slope FEV1/FVC % ratio 2.684 <0.00001
VImax –1.184 0.004
PEmax –0.811 0.029
VAS/VI intercept VAS/VI r
2 value 0.932 <0.00001
FEV1/FVC % ratio = ratio of FEV1 to FVC; PEmax = maximum
static expiratory mouth pressure; r2 = coefficient of determination;
VAS/VI = relationship of visual analogue scale against inspired
ventilation; VImax = maximum ventilation.
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(26), and greater respiratory work (27). A greater work
of breathing suggests a decreased ventilatory reserve,
which predisposes these persons to respiratory
failure and developing dyspnoea. Weight reduction
in the obese, by diet and exercise or surgery, can
improve dyspnoea (26). Most of our OW subjects
were not obese, and they were unlikely to possess
the respiratory and haemodynamic alterations
mentioned above, especially since their lung
function was better than that of the NW subjects
in our study.
The current hypothesis for the genesis of dyspnoea is
that output of the central motor command from
the brainstem to the respiratory muscles is also
projected to the sensory cortex (1). Human neuro-
imaging has shown that the insula is essential for
dyspnoea perception (28). It has been suggested that
the sensory cortex interacts with the insular cortex to
modulate the dyspnoea intercept (4). It could be
possible that our UW subjects, who had weaker
respiratory muscles, had a greater efferent output
from the brainstem, thereby increasing their dyspnoea.
In OW subjects, the excess body mass could result in
a greater work of breathing and more afferent input
to the brainstem, which would again result in a greater
efferent output from the brainstem. It is unclear as to
why the threshold (intercept) and not the gain (slope)
are affected by BMI.
Limitations of the present study are that a larger
sample size for each group could have shown more
definitive results. The study participants were all men,
therefore extrapolating the results to women cannot
be done. In the present study we have speculated that
changes in the VAS/VI intercept in UW subjects were
most likely due to changes in RMS. An alternative
explanation could be that this group was less physi-
cally active and conditioned than the other group;
however, when exercise heart rates were compared,
there were no significant differences. Another limita-
tion of this study is that we could not distinguish
whether changes in BMI were due to changes in lean
tissue mass or fat mass. In addition, most of our
subjects were sedentary individuals with poor levels
of physical fitness. This might limit generalizing the
results with a population having normal or good levels
of physical fitness.
The OW group had eight overweight and five obese
subjects; their mean BMI was 29 kg m-2. For logistical
reasons they were combined into one group, due to
the small number of subjects in each group and also
the fact that four obese subjects had a borderline
overweight/obese class I BMI (30–31 kg m-2). VAS/VI
intercept and slope data were tested and showed no
significant differences between these overweight and
obese subjects. Therefore, it was expected that this
combination would have no material effect on the
results.
It has been recommended that patients with
respiratory disease should attempt to keep their
BMI in the normal range (29), and our study has
shown that this recommendation, with regard to the
symptoms of dyspnoea and lung function, should be
extended to healthy subjects. Additionally, previous
work has shown that men with an abnormal BMI are
at an increased risk of developing COPD (8), were
associated with a higher prevalence of asthma (9), and
in asthma would have a greater decline in FEV1 (30).
We strongly agree with a suggestion that future
clinical breathlessness studies should consider data
stratification by BMI (10).
In conclusion, this study has shown that UW and
OW healthy subjects showed greater levels of dys-
pnoea during exercise compared to NW subjects.
Higher levels of dyspnoea could possibly result
from a decrease in RMS. The reason for the greater
dyspnoea of OW subjects could be an increase in the
work of breathing. Implications from this study are
that UW and OW subjects might be more susceptible
to increased dyspnoea if they develop lung disease
and, secondly, that caution is needed in clinical or
mechanistic trials using subjects with abnormal body
mass indices or body fat and varied levels of physical
activity.
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